Received Mar 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | E2JX7 | IM / LA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z014411 | SC / LA |
Severity is 5. It occurs continuously. Location is arm. The describes the rash as erythematous, inflamed and macular. Additional information: Pt received vaccines on 1/14 Kinrix ad MMRV same arm.
NA
NA
NA
NKDA
NA